19 results on '"Aschero, S"'
Search Results
2. Syndecan-1 promotes the angiogenic phenotype of multiple myeloma endothelial cells
3. A comprehensive diagnostic surveillance protocol for idiopathic (de novo) and secondary myelodysplastic syndromes in childhood
4. Chromosome 1 abnormalities in newly diagnosed elderly multiple myeloma patients treated with novel therapies
5. 12p, 1p, 1q, 5q, 11q ABNORMALITIES AND IMMUNOPHENOTYPE IN MONOCLONAL GAMMOPATHY OF UNDETERMINED SIGNIFICANCE, MULTIPLE MYELOMA AND PLASMA CELL LEUKEMIA
6. CHROMOSOMAL ABNORMALITIES AND IMMUNOPHENOTYPE IN ELDERLY MULTIPLE MYELOMA PATIENTS AT DIAGNOSIS ENTERED IN A PROSPECTIVE RANDOMIZED TRIAL OF VELCADE-MELPHALAN-PREDNISONE AND THALIDOMIDE VS VELCADE-MELPHALAN-PREDNISONE
7. Chromosome 1 abnormalities in elderly patients with newly diagnosed multiple myeloma treated with novel therapies
8. Syndecan-1 promotes the angiogenic phenotype of multiple myeloma endothelial cells
9. P017 Transient leukemia in Down syndrome newborns
10. Evaluation of cryptic chromosomal aberrations using fluorescence in situ hybridisation (fish) in children with primary and secondary myelodysplastic syndromes
11. Therapy-related myelodysplastic syndromes in childhood: Report on a diagnostic surveillance protocol in a single institution
12. Case forum: Therapy-related myelodysplastic syndrome in a child during treatment for acute lymphoblastic leukemia: A case report
13. ADVANCED AGE, ORGAN DAMAGE AND ADVERSE EVENTS NEGATIVELY AFFECT SURVIVAL OF MYELOMA PATIENTS RECEIVING NOVEL AGENTS: A META-ANALYSIS OF 1435 INDIVIDUAL PATIENT DATA FROM 4 RANDOMIZED CLINICAL TRIALS
14. CYCLOPHOSPHAMIDE-LENALIDOMIDE-DEXAMETHASONE VS ASCT, FOLLOWED BY MAINTENANCE WITH LENALIDOMIDE-PREDNISONE VS LENALIDOMIDE ALONE IN NEWLY DIAGNOSED MM PATIENTS: A PHASE 3 RANDOMIZED EMN TRIAL
15. Loss of 10q26.1-q26.3 in association with 7q34-q36.3 gain or 17q24.3-q25.3 gain predict poor outcome in pediatric medulloblastoma.
16. Loss of 10q26.1-q26.3 in association with 7q34-q36.3 gain or 17q24.3-q25.3 gain predict poor outcome in pediatric medulloblastoma
17. MET dysregulation is a hallmark of aggressive disease in multiple myeloma patients.
18. A complex karyotype including a t(2;11) in a paediatric ependymoma: case report and review of the literature.
19. Expansion of mesenchymal stem cells isolated from pediatric and adult donor bone marrow.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.